All In Biotech

Free tool

FAERS Monitor: Tobrex

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 050555 or its brand name (Tobrex, Tobramycin). Reports on generic versions are filed under their own applications.

Reports

12,764

Serious

10,320

81% of reports

Hospitalization

6,109

Death reported

1,284

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • off label use795
  • pneumonia776
  • drug ineffective727
  • acute kidney injury702
  • dyspnoea696
  • infective pulmonary exacerbation of cystic fibrosis611
  • death488
  • cough464
  • condition aggravated457
  • hospitalisation456
  • infection453
  • pyrexia436
  • cystic fibrosis418
  • fatigue412
  • nausea387

Reports by year received

View as table
YearReports
200485
2005102
200683
2007129
2008110
2009103
2010117
2011220
2012211
2013194
2014294
2015469
2016538
2017594
20181,083
20191,574
20201,391
20211,036
2022972
2023825
20241,046
2025895
2026692

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,041,395 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
infective pulmonary exacerbation of cystic fibrosisSignal611208.2191.8111,725
cystic fibrosisSignal418134.5121.951,092
acute kidney injurySignal7027.67.14,020
infectionSignal4535.24.71,525
hospitalisationSignal4564.94.51,419
pneumoniaSignal7764.03.71,734
coughSignal4642.72.5513
condition aggravatedSignal4572.52.3407
pyrexiaSignal4362.11.9246
dyspnoeaSignal6962.01.9371
off label use7951.51.4136
death4880.90.92
drug ineffective7270.90.87
fatigue4120.90.88
nausea3870.80.719

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.